PFKM and Sepsis: Furthermore, targeting key metabolic enzymes, such as the muscle-type 6-phosphofructokinase (PFKM), to inhibit glycolysis has demonstrated protective effects against sepsis-induced cytokine storms and organ damage (122–125).